Search

everythinglearnresearchcommunity

for

Search:↓

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Drug repositioning can save time and money but needs more support.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

The combination therapy was effective and well-tolerated, especially in young patients.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

Monoclonal antibody B72.3 selectively reacts with certain dog tissues, mainly in the gastrointestinal and respiratory tracts.

A new hair loss treatment using dissolving microneedles was found to speed up hair growth and was more effective than daily use of common hair growth drugs.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

The DNN-DTIs method accurately predicts drug-target interactions and is useful for drug repositioning.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Thymosin beta 4 protects cells from damage by blocking a harmful microRNA and boosting a protective gene.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Biosimilars lower costs but don't significantly improve access.

Targeting regulatory T cells may help treat age-related diseases.

Advanced delivery systems can make dithranol more effective and less irritating for treating psoriasis.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Nanoparticles can effectively treat diseases by modifying blood vessel growth.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Thyroid receptor β can help develop new drugs to treat hair loss.

New methods like nanoparticles and microneedles show promise for better skin drug delivery, especially for hair disorders.

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

A new AI-driven method shows promise for treating hair loss with a peptide-based drug.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.